Compare Humana Inc (HUM) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Humana Inc trades at $407.05 (market cap $47.81B), while Invesco S&P 500 High Div Low Volatility ETF trades at $52.11. The key difference: Humana Inc pays a 0.89% dividend while Invesco S&P 500 High Div Low Volatility ETF pays none, and Humana Inc is trading nearer its 52-week high, Invesco S&P 500 High Div Low Volatility ETF nearer its low. Which is the better fit depends on your goals.
| HUM | SPHD | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | — |
52-Week High | $409.42 | $53.18 |
52-Week Low | $163.67 | $46.96 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
SPHD trades at $52.39, down 0.91% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering a 4.5% yield with monthly distributions. Recent news highlights its defensive appeal for retirees seeking stable income amid market uncertainty, though it has underperformed the broader S&P 500 historically.
Outlook remains cautious; SPHD provides income stability but faces growth limitations. Risks include interest rate sensitivity and sector concentration. Analyst sentiment is mixed, with upgrades citing defensive positioning but noting long-term performance gaps versus the market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
